NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

DXCM

Dexcom Inc

Jun 20 • 04:00PM ET

80.00

Dollar change -1.01
Percentage change -1.25	%

Healthcare • Medical Devices • USA • NASD

Peers: ABT MDT TNDM PODD BSX SENS GMED ZBH SYK TDOC

| Held by: VTI VOO VO QQQ VUG SPY IVV VOT XLV IWP

Scroll to Statements

Index	NDX, S&P 500	P/E	60.06	EPS (ttm)	1.33	Insider Own	1.44%	Shs Outstand	392.10M	Perf Week	-3.44%
Market Cap	31.37B	Forward P/E	31.46	EPS next Y	2.54	Insider Trans	-2.71%	Shs Float	386.48M	Perf Month	-8.40%
Enterprise Value	31.25B	PEG	2.50	EPS next Q	0.44	Inst Own	93.56%	Short Float	2.69%	Perf Quarter	6.51%
Income	535.20M	P/S	7.56	EPS this Y	23.68%	Inst Trans	1.44%	Short Ratio	2.60	Perf Half Y	4.70%
Sales	4.15B	P/B	13.84	EPS next Y	25.37%	ROA	8.09%	Short Interest	10.41M	Perf YTD	2.87%
Book/sh	5.78	P/C	11.61	EPS next 5Y	23.98%	ROE	23.72%	52W Range	57.52 - 117.27	Perf Year	-31.35%
Cash/sh	6.89	P/FCF	54.54	EPS past 3/5Y	41.20% 39.06%	ROIC	14.78%	52W High	-31.78%	Perf 3Y	15.42%
Dividend Est.	-	EV/EBITDA	36.43	Sales past 3/5Y	18.10% 22.27%	Gross Margin	59.43%	52W Low	39.08%	Perf 5Y	-19.75%
Dividend TTM	-	EV/Sales	7.53	EPS Y/Y TTM	-17.87%	Oper. Margin	15.25%	Volatility	1.24% 1.26%	Perf 10Y	336.03%
Dividend Ex-Date	-	Quick Ratio	1.32	Sales Y/Y TTM	9.11%	Profit Margin	12.90%	RSI (14)	40.26	Recom	1.47
Dividend Gr. 3/5Y	- -	Current Ratio	1.50	EPS Q/Q	-25.82%	SMA20	-5.15%	Beta	1.46	Target Price	100.36
Payout	0.00%	Debt/Eq	1.14	Sales Q/Q	12.49%	SMA50	0.76%	Rel Volume	1.24	Prev Close	81.01
Employees	10300	LT Debt/Eq	0.60	Earnings	May 01 AMC	SMA200	4.12%	Avg Volume	4.00M	Price	80.00
IPO	Apr 14, 2005	Option/Short	Yes / Yes	EPS/Sales Surpr.	-2.20% 1.83%	Trades		Volume	4,959,674	Change	-1.25%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-16-25	Initiated	Truist	Buy	$102
May-30-25	Initiated	Goldman	Buy	$104
Apr-10-25	Initiated	Mizuho	Outperform	$85
Feb-03-25	Upgrade	Redburn Atlantic	Neutral → Buy	$85 → $115
Jan-16-25	Upgrade	Robert W. Baird	Neutral → Outperform	$86 → $104
Jul-26-24	Downgrade	Robert W. Baird	Outperform → Neutral	$161 → $80
Jul-26-24	Downgrade	JP Morgan	Overweight → Neutral	$145 → $75
May-30-24	Initiated	Redburn Atlantic	Neutral	$130
Mar-12-24	Initiated	RBC Capital Mkts	Outperform	$165
May-30-23	Resumed	Morgan Stanley	Equal-Weight	$131
Apr-17-23	Upgrade	Raymond James	Outperform → Strong Buy	$127 → $138
Mar-29-23	Initiated	UBS	Buy	$142
Jan-26-23	Initiated	Wolfe Research	Outperform	$121
Oct-18-22	Initiated	Barclays	Equal Weight	$103
Oct-12-22	Initiated	Jefferies	Buy	$125
Jul-15-22	Initiated	Bernstein	Outperform	$105
Mar-02-22	Resumed	BofA Securities	Buy	$500
Feb-03-22	Upgrade	BTIG Research	Neutral → Buy	$535
Jan-19-22	Upgrade	Wells Fargo	Equal Weight → Overweight	$575
Jan-07-22	Upgrade	Guggenheim	Neutral → Buy	$580

Show Previous Ratings

Jun-20-25 09:25AM	DXCM's Access Gains and Operational Strength Offset Margin Pressures (Zacks)
07:06AM	5 things to watch at the ADAs Scientific Sessions (MedTech Dive)
Jun-18-25 08:30AM	Dexcom Unveils New Report on Type 2 Diabetes Management in the U.S. at ADA 2025 (Business Wire)
06:58AM	Dexcom recalls more than 2 million CGM receivers for lack of audible alarm (MedTech Dive)
Jun-17-25 11:33PM	Q1 Rundown: DexCom (NASDAQ:DXCM) Vs Other Patient Monitoring Stocks (StockStory)
09:35AM	Loading…
09:35AM	Cisco upgraded, CoreWeave downgraded: Wall Streets top analyst calls (TipRanks)
Jun-16-25 10:21AM	Truist starts on diabetes device makers, sees glucose monitor, insulin pump growth (Investing.com)
Jun-09-25 09:45AM	Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
06:20AM	Is Invesco S&P 500 Equal Weight Health Care ETF (RSPH) a Strong ETF Right Now? (Zacks)
Jun-06-25 04:08PM	Healthcare companies are hiring. Is it time to look for growth stocks in this beaten-down sector? (MarketWatch)
Jun-04-25 10:31AM	Profit From the Silver Tsunami: Must-Watch Senior Care & Aging Stocks (Zacks)
Jun-01-25 09:00AM	A Glucose Monitor for Someone Without Diabetes: Optimal or Overkill? (The Wall Street Journal)
May-30-25 10:17AM	Goldman Sachs initiates coverage of medtech stocks Insulet and Dexcom at Buy (Investing.com)
May-27-25 03:46AM	Prediction: These 2 Stocks Will Beat the Market in the Next Decade (Motley Fool)
May-23-25 08:41AM	QGEN Stock Might Gain Following New Partnership With ID Solutions (Zacks)
08:26AM	Loading…
May-22-25 08:26AM	Walgreens Opens New Micro-Fulfillment Center in Brooklyn Park (Zacks)
06:20AM	Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RSPH)? (Zacks)
May-20-25 07:53AM	Neogen Stock Gains Following Strategic Alliance With Syngenta (Zacks)
12:00AM	3 Big Reasons to Love DexCom (DXCM) (StockStory)
May-16-25 08:00AM	Here's Why You Should Add DexCom Stock to Your Portfolio Now (Zacks)
07:59AM	ALGN Stock Might Rise Following the NMPA Approval in China (Zacks)
05:51AM	Dexcom CEO says CGMs fit MAHA agenda very nicely; Tandem preps for new products (MedTech Dive)
May-15-25 05:21PM	DXCM Q1 Earnings Call: Coverage Expansion and Product Pipeline Shape 2025 Outlook (StockStory)
08:06AM	5 High-Flying Medical Instrument Stocks to Buy Despite Recent Turmoil (Zacks)
May-14-25 08:57AM	Top Health & Fitness Stocks to Buy for the Wellness Boom (Zacks)
May-13-25 10:21AM	The Zacks Analyst Blog Highlights Sprouts Farmers Market, DexCom, Hims & Hers Health, United Natural Foods and GoodRx (Zacks)
08:30AM	Dexcom Announces Promotion of Jake Leach to the Expanded Role of President and COO (Business Wire)
07:07AM	QIAGEN Stock Gains Following the Acquisition of Genoox (Zacks)
May-12-25 12:00PM	All You Need to Know About DexCom (DXCM) Rating Upgrade to Buy (Zacks)
09:06AM	Buy 5 Health and Fitness Stocks to Enhance Your Portfolio Returns (Zacks)
06:34AM	Loading…
May-09-25 06:34AM	Is DexCom, Inc. (DXCM) the Best Medical Device Stock to Buy Now? (Insider Monkey)
May-08-25 07:30AM	DexCom Stock: Earnings Beat and New Market Access Drive Bull Case (MarketBeat)
May-07-25 07:17PM	Tracking Baillie Gifford's 13F Portfolio - Q1 2025 Update (Seeking Alpha)
07:04PM	DexCom, Inc. (DXCM): A Bull Case Theory (Insider Monkey)
May-06-25 12:00PM	URA rolls out glucose app linked with Dexcoms CGM Stelo (Medical Device Network)
May-05-25 10:46AM	5 Best Stocks of the S&P 500 ETF in the Past Month (Zacks)
09:21AM	DexCom (DXCM) Jumps 15% After Q1 Revenue Beat, $750M Buyback (GuruFocus.com)
04:34AM	DexCom: Growth Is Reaccelerating But Don't Ignore The Risks (Seeking Alpha)
May-04-25 05:40AM	Why DexCom Inc. (DXCM) Soared Last Week (Insider Monkey)
May-03-25 06:47AM	What Moved Markets This Week (Seeking Alpha)
May-02-25 10:23PM	Why DexCom, Inc. (DXCM) Went Up On Friday (Insider Monkey) +16.17%
07:31PM	Analyst Report: DexCom, Inc. (Morningstar Research)
04:43PM	S&P 500 Gains and Losses Today: Index Climbs as Strong Jobs Report Alleviates Economic Concerns (Investopedia)
02:33PM	DexCom Stock Rockets Higher To Lead S&P 500 Gainers (Investopedia)
01:21PM	DexCom Stock Rises Despite Q1 Earnings Miss & Lower Margins (Zacks)
11:57AM	Top Stock Movers Now: Dexcom, Berkshire Hathaway, Nvidia, and More (Investopedia)
11:53AM	Dexcom Stock Is Todays Big Winner After Earnings. Why the Medtech Is Soaring. (Barrons.com)
09:35AM	Q1 2025 Dexcom Inc Earnings Call (Thomson Reuters StreetEvents)
04:16AM	2 Growth Stocks to Buy and Hold for a Decade (Motley Fool)
03:17AM	DexCom Inc (DXCM) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Supply Challenges (GuruFocus.com)
May-01-25 09:04PM	DexCom, Inc. (DXCM) Q1 2025 Earnings Call Transcript (Seeking Alpha)
05:30PM	Compared to Estimates, DexCom (DXCM) Q1 Earnings: A Look at Key Metrics (Zacks)
05:15PM	DexCom (DXCM) Q1 Earnings Miss Estimates (Zacks)
04:14PM	DexCom: Q1 Earnings Snapshot (Associated Press Finance)
04:02PM	Dexcom Reports First Quarter 2025 Financial Results and Announces $750 Million Share Repurchase Program (Business Wire)
Apr-30-25 10:54AM	MedTech Stocks' Earnings to Watch on May 1: BDX, CAH, BAX, DXCM & SYK (Zacks)
Apr-29-25 09:15AM	Gear Up for DexCom (DXCM) Q1 Earnings: Wall Street Estimates for Key Metrics (Zacks)
09:05AM	DXCM Q1 Earnings to Reflect U.S. Coverage Expansion & Stelo Impact? (Zacks)
Apr-22-25 08:00AM	Dexcom Launches First Nationwide Search for College Athletes With Diabetes to Join Season Four of Dexcom U (Business Wire)
Apr-21-25 07:30AM	3 New ETFs Finding Early Traction With Investors (MarketBeat)
Apr-16-25 10:19AM	Tariffs, Trump, and Turmoil (Motley Fool)
Apr-14-25 03:00PM	Tap Into the Silver Economy Boom With These Aging Demographics Stocks (Zacks)
Apr-11-25 01:01PM	DexCom Shares May Rise as G7 15-Day CGM System Gets FDA Clearance (Zacks)
12:08PM	Analyst Report: DexCom, Inc. (Morningstar Research)
12:05PM	Prada to acquire Versace, CarMax reports mixed Q4 results: Morning Buzz (TipRanks)
Apr-10-25 01:37PM	FDA Approves New DexCom Diabetes Device (Investopedia)
01:28PM	FDA Approves Dexcom's 15-Day Wearable Glucose Management System. Company Plans US Launch (Benzinga)
11:34AM	DexCom Stock Rises as Glucose Monitoring System Gets FDA Clearance (Barrons.com)
10:15AM	2 Growth Stocks to Buy in the Tariff-Fueled Market Correction (Motley Fool)
10:07AM	Dexcom nets FDA clearance for 15-day CGM (MedTech Dive)
09:34AM	Dexcom Surges After FDA Clears Its Next-Generation Diabetes Device (Investor's Business Daily)
08:30AM	Dexcom G7 15 Day Receives FDA Clearance: the Longest Lasting Wearable and Most Accurate CGM System (Business Wire)
Apr-04-25 08:06AM	Here's Why You Should Retain DexCom Stock in Your Portfolio for Now (Zacks)
Apr-03-25 02:22PM	Analyst Report: DexCom, Inc. (Morningstar Research) -9.30%
08:30AM	Dexcom Schedules First Quarter 2025 Earnings Release and Conference Call for May 1, 2025 at 4:30 p.m. Eastern Time. (Business Wire)
Apr-01-25 08:59AM	DexCom (DXCM) Slid on Poor Execution and GLP-1 Drug Disruption Concerns (Insider Monkey)
08:00AM	Government of Saskatchewan Expands Public Coverage for Dexcom Continuous Glucose Monitoring Systems (Business Wire)
Mar-31-25 09:30AM	DXCM Inks Deal With Nanowear to Boost CGM Application Beyond Diabetes (Zacks)
Mar-28-25 01:38PM	Baird Q4 2024 Mid Cap Growth Strategy Commentary (Seeking Alpha)
Mar-27-25 11:40AM	Dexcom rejects claims of unauthorized device changes in FDA warning letter (MedTech Dive)
09:04AM	DXCM Stock Falls as FDA Warnings Raise Concern for 15-Day G7 Approval (Zacks)
Mar-26-25 07:31AM	Dexcoms FDA warning letter reveals unauthorized changes to sensors (MedTech Dive)
07:17AM	DXCM Stock Gains Following New Data on Upcoming G7 CGM Sensor (Zacks)
Mar-25-25 04:05PM	Dexcom Appoints Jon Coleman as Chief Commercial Officer (Business Wire)
07:38AM	Dexcom COO on 15-day glucose sensor, Type 2 coverage (MedTech Dive)
Mar-24-25 05:10AM	DexCom (DXCM): 3 Reasons We Love This Stock (StockStory)
Mar-19-25 10:02AM	Nasdaq Sell-Off: 2 Brilliant Stocks to Buy No Matter What the Market Does Next (Fool)
04:00AM	Dexcom Report Unveiled at ATTD 2025 Reveals HCPs Favour Tech Over Medication for Future of Type 2 Care (Business Wire)
Mar-18-25 01:43PM	DexCom, Inc. (DXCM): Among the Best Diabetes Stocks to Buy According to Billionaires (Insider Monkey)
Mar-11-25 02:15PM	Analysts say Dexcoms FDA warning unlikely to impact 2025 revenue (Medical Device Network)
05:07AM	Patient Monitoring Stocks Q4 Results: Benchmarking ResMed (NYSE:RMD) (StockStory)
Mar-10-25 07:31PM	Analyst Report: DexCom, Inc. (Morningstar Research) -9.15%
04:29PM	Why Dexcom Is On A Six-Day Losing Spree But This Analyst Isn't Worried (Investor's Business Daily)
11:53AM	Top Stock Movers Now: Tesla, DexCom, Strategy, and More (Investopedia)
10:15AM	DexCom Stock Drops as Diabetes Devices Maker Gets FDA Warning Letter (Investopedia)
08:30AM	Dexcom Appoints Rene Gal to Board of Directors (Business Wire)
02:57AM	Dexcom receives warning letter based on FDA inspections of 2 plants (MedTech Dive)
Mar-08-25 08:17AM	Is DexCom, Inc. (DXCM) the Best Growth Stock Under $100 to Buy Now? (Insider Monkey)
Mar-07-25 05:51PM	Dexcom receives FDA warning letter for two U.S. manufacturing facilities (Reuters) -9.15%
05:33PM	DexCom Gets FDA Warning Letter After Inspections of Facilities (The Wall Street Journal)

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
FOLETTA MARK G	Director	Jun 16 '25	Sale	83.13	2,750	228,605	56,621	Jun 18 04:31 PM
Brown Michael Jon	EVP, Chief Legal Officer	Jun 16 '25	Sale	82.80	500	41,400	95,102	Jun 18 04:31 PM
AUGUSTINOS NICHOLAS	Director	Jun 16 '25	Sale	82.80	3,672	304,042	33,411	Jun 17 05:33 PM
AUGUSTINOS NICHOLAS	Director	Jun 13 '25	Sale	81.69	2,618	213,864	37,083	Jun 17 05:33 PM
MICHAEL BROWN	Officer	Jun 16 '25	Proposed Sale	82.80	500	41,400		Jun 16 04:12 PM
FOLETTA MARK G	Director	Jun 16 '25	Proposed Sale	82.80	2,750	227,700		Jun 16 04:02 PM
AUGUSTINOS NICHOLAS	Director	Jun 09 '25	Proposed Sale	86.91	6,290	546,664		Jun 09 03:59 PM
Stern Sadie	EVP, Chief HR Officer	May 27 '25	Sale	85.11	6,184	526,318	109,621	May 28 04:51 PM
Brown Michael Jon	EVP, Chief Legal Officer	May 23 '25	Sale	84.28	10,000	842,849	95,602	May 28 04:50 PM
SADIE STERN	Officer	May 27 '25	Proposed Sale	85.11	6,184	526,318		May 27 04:18 PM
MICHAEL BROWN	Officer	May 23 '25	Proposed Sale	84.28	10,000	842,849		May 23 04:04 PM
Heller Bridgette P	Director	Mar 17 '25	Sale	70.33	352	24,756	22,997	Mar 19 05:02 PM
Heller Bridgette P	Director	Mar 17 '25	Proposed Sale	70.33	352	24,756		Mar 17 09:40 AM
Leach Jacob Steven	EVP, Chief Operating Officer	Mar 12 '25	Sale	70.38	14,076	990,670	313,497	Mar 14 05:25 PM
Brown Michael Jon	EVP, Chief Legal Officer	Mar 12 '25	Sale	70.38	13,000	914,941	105,602	Mar 14 05:25 PM
Sylvain Jereme M	EVP, Chief Financal Officer	Mar 12 '25	Sale	70.38	12,001	844,632	123,481	Mar 14 05:25 PM
Stern Sadie	EVP, Chief HR Officer	Mar 12 '25	Sale	70.38	11,176	786,568	115,805	Mar 14 05:25 PM
SAYER KEVIN R	Chairman, CEO & President	Mar 12 '25	Sale	70.38	32,498	2,287,212	372,029	Mar 14 05:24 PM
Sylvain Jereme M	EVP, Chief Financal Officer	Mar 10 '25	Sale	73.83	7,000	516,830	135,482	Mar 11 07:17 PM
JEREME SYLVAIN	Officer	Mar 10 '25	Proposed Sale	73.83	7,000	516,830		Mar 10 04:03 PM
Sylvain Jereme M	EVP, Chief Financal Officer	Jan 29 '25	Sale	86.91	2,090	181,650	83,526	Jan 30 06:44 PM
Dolan Matthew Vincent	EVP, Strategy & Corporate Dev	Jan 29 '25	Sale	86.91	1,183	102,820	42,044	Jan 30 06:44 PM
Stern Sadie	EVP, Chief HR Officer	Jan 29 '25	Sale	86.91	2,093	181,911	74,261	Jan 30 06:44 PM
Leach Jacob Steven	EVP, Chief Operating Officer	Jan 29 '25	Sale	86.91	2,634	228,932	268,644	Jan 30 06:44 PM
SAYER KEVIN R	Chairman, CEO & President	Jan 29 '25	Sale	86.91	33,359	2,899,367	319,037	Jan 30 06:43 PM
Stern Sadie	EVP, Chief HR Officer	Dec 16 '24	Sale	76.87	424	32,593	70,768	Dec 17 04:15 PM
Sylvain Jereme M	EVP, Chief Financal Officer	Dec 16 '24	Sale	76.87	744	57,191	80,030	Dec 17 04:15 PM
Leach Jacob Steven	EVP, Chief Operating Officer	Dec 16 '24	Sale	76.87	744	57,191	264,171	Dec 17 04:15 PM
Heller Bridgette P	Director	Dec 16 '24	Sale	76.87	1,000	76,870	23,349	Dec 17 04:15 PM
Heller Bridgette P	Director	Dec 16 '24	Proposed Sale	76.87	1,000	76,870		Dec 16 11:56 AM
Stern Sadie	EVP, Chief HR Officer	Nov 20 '24	Sale	74.73	4,259	318,275	71,192	Nov 22 04:15 PM
Sylvain Jereme M	EVP, Chief Financal Officer	Nov 15 '24	Sale	75.51	3,500	264,285	80,774	Nov 18 04:12 PM
JEREME SYLVAIN	Officer	Nov 15 '24	Proposed Sale	75.51	3,500	264,285		Nov 15 04:04 PM
Heller Bridgette P	Director	Sep 16 '24	Sale	70.00	1,000	70,000	24,349	Sep 17 04:17 PM
Heller Bridgette P	Director	Sep 16 '24	Proposed Sale	70.00	1,000	70,000		Sep 16 09:53 AM
Stern Sadie	EVP, Chief HR Officer	Sep 09 '24	Sale	69.15	426	29,458	75,451	Sep 11 07:05 PM
Sylvain Jereme M	EVP, Chief Financal Officer	Sep 09 '24	Sale	69.15	746	51,586	84,274	Sep 11 07:05 PM
Leach Jacob Steven	EVP, Chief Operating Officer	Sep 09 '24	Sale	69.15	746	51,586	264,915	Sep 11 07:05 PM
Brown Michael Jon	EVP, Chief Legal Officer	Aug 30 '24	Sale	70.00	686	48,020	65,636	Sep 03 04:22 PM
MICHAEL BROWN	Officer	Aug 30 '24	Proposed Sale	70.00	686	48,020		Aug 30 04:32 PM
Brown Michael Jon	EVP, Chief Legal Officer	Jul 31 '24	Sale	69.55	652	45,347	66,249	Aug 01 07:23 PM
MICHAEL BROWN	Officer	Jul 31 '24	Proposed Sale	69.55	652	45,347		Jul 31 04:04 PM
Brown Michael Jon	EVP Chief Legal Officer	Jun 28 '24	Sale	114.29	659	75,317	66,901	Jun 28 05:34 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

DXCM

Dexcom Inc

Upgrade your FINVIZ experience